You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-NFkB p100 / p52 antibody (ab31432)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab31432? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab31432 has been referenced in 1 publications.

  1. Alameda JP et al. An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Oncogene : (2010). WB; Human. PubMed: 20838385

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"